Chao Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chao Wang has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Jinhui Wu
Jiangsu Key Laboratory for Nano Technology, Nanjing University, Nanjing, 210093, P. R. China
4 shared publications - Yiqiao Hu
State Key Laboratory of Pharmaceutical Biotechnology, Medical School & School of Life Sciences, Nanjing University, Nanjing, China
3 shared publications Ahu Yuan
State Key Laboratory of Pharmaceutical Biotechnology, Medical School and School of Life Sciences of Nanjing University, Nanjing University, Nanjing, 210093, China; Jiangsu Key Laboratory for Nano Technology, Nanjing University, Nanjing, 210093, China
2 shared publicationsHonghui Liu
State Key Laboratory of Pharmaceutical Biotechnology, Medical School and School of Life Sciences of Nanjing University, Nanjing University, Nanjing, 210093, China
2 shared publications- Jianqiu Chen
School of Engineering, China Pharmaceutical University, Nanjing, China
2 shared publications Yilong Su
Department of Analytical Chemistry
2 shared publications
Latest Publications
- Open Access
- 21 September 2026
- Published by Wiley in Advanced Science
- p. e77614
Ribonucleotides Amplify Mitochondrial DNA‐Driven cGAS–STING Activation via FdUMP‐ribonucleotide Hybrid Particles to Potentiate Chemoimmunotherapy
Intracellular nucleotide imbalance between ribonucleotides and deoxyribonucleotides can trigger cytosolic mitochondrial DNA (mtDNA) release and subsequent activation of the cGAS–STING pathway. However, fluoropyrimidine‐induced nucleotide imbalance is constrained by their metabolic instability. Here, we leverage ribonucleotides to amplify floxuridine (FUDR)‐induced mtDNA release and cGAS–STING activation for enhanced cancer chemoimmunotherapy. We identified that cytidine monophosphate (CMP) significantly enhances FUDR‐mediated activation of the mtDNA‐driven cGAS–STING pathway, inducing over 300‐fold upregulation of the interferon gene Ifnb1 and initiating STING‐dependent antitumor immunity. Genome‐wide CRISPR‐Cas9 screening identified five pyrimidine‐metabolizing enzymes (CMPK1, CMPK2, TYMP, UPP1, and UPP2) that are responsible for the metabolic instability of floxuridine monophosphate (FdUMP). CMP and its intracellular metabolites can metabolically block these enzymes, thereby increasing the peak intracellular concentration of FdUMP by over 500‐fold and extending its half‐life by more than 20‐fold, which in turn promotes sustained intracellular nucleotide imbalance. To translate this mechanism into therapy, we co‐encapsulated FdUMP and CMP into hybrid lipid nanoparticles (FC‐NPs). FC‐NPs robustly activated STING‐dependent antitumor immunity, achieving remarkable therapeutic efficacy in multiple murine colorectal cancer (CRC) models. Our study not only addresses the long‐standing issue of fluoropyrimidine metabolic instability but also reveals a novel ribonucleotide‐mediated immunomodulatory mechanism, providing a promising strategy to potentiate chemoimmunotherapy in CRC.
- 21 September 2026
- Published by Wiley in Advanced Science
- p. e77614
Open AccessRibonucleotides Amplify Mitochondrial DNA‐Driven cGAS–STING Activation via FdUMP‐ribonucleotide Hybrid Particles to Potentiate Chemoimmunotherapy
Intracellular nucleotide imbalance between ribonucleotides and deoxyribonucleotides can trigger cytosolic mitochondrial DNA (mtDNA) release and subsequent activation of the cGAS–STING pathway. However, fluoropyrimidine‐induced nucleotide imbalance is constrained by their metabolic instability. Here, we leverage ribonucleotides to amplify floxuridine (FUDR)‐induced mtDNA release and cGAS–STING activation for enhanced cancer chemoimmunotherapy. We identified that cytidine monophosphate (CMP) significantly enhances FUDR‐mediated activation of the mtDNA‐driven cGAS–STING pathway, inducing over 300‐fold upregulation of the interferon gene Ifnb1 and initiating STING‐dependent antitumor immunity. Genome‐wide CRISPR‐Cas9 screening identified five pyrimidine‐metabolizing enzymes (CMPK1, CMPK2, TYMP, UPP1, and UPP2) that are responsible for the metabolic instability of floxuridine monophosphate (FdUMP). CMP and its intracellular metabolites can metabolically block these enzymes, thereby increasing the peak intracellular concentration of FdUMP by over 500‐fold and extending its half‐life by more than 20‐fold, which in turn promotes sustained intracellular nucleotide imbalance. To translate this mechanism into therapy, we co‐encapsulated FdUMP and CMP into hybrid lipid nanoparticles (FC‐NPs). FC‐NPs robustly activated STING‐dependent antitumor immunity, achieving remarkable therapeutic efficacy in multiple murine colorectal cancer (CRC) models. Our study not only addresses the long‐standing issue of fluoropyrimidine metabolic instability but also reveals a novel ribonucleotide‐mediated immunomodulatory mechanism, providing a promising strategy to potentiate chemoimmunotherapy in CRC.
- 1 February 2021
- Published by Elsevier in Biomaterials
- Vol. 269, 120621
Light-controlled oxygen production and collection for sustainable photodynamic therapy in tumor hypoxia
- 1 February 2021
- Published by Elsevier in Biomaterials
- Vol. 269, 120621
Light-controlled oxygen production and collection for sustainable photodynamic therapy in tumor hypoxia
- Open Access
- 1 January 2021
- Published by Shanghai Institute of Organic Chemistry in Chinese Journal of Organic Chemistry
- Vol. 41 (6) , 2417-2423
A Long-Wavelength Fluorescent Probe for Naked Eye Recognition of HSO3-/SO32-in Aqueous Solution and Its Application
- 1 January 2021
- Published by Shanghai Institute of Organic Chemistry in Chinese Journal of Organic Chemistry
- Vol. 41 (6) , 2417-2423
Open AccessA Long-Wavelength Fluorescent Probe for Naked Eye Recognition of HSO3-/SO32-in Aqueous Solution and Its Application
- 1 February 2020
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 180, 113072
Using HPLC to analyze (S)-oxiracetam and four related substances in the bulk drug of (S)-oxiracetam
- 1 February 2020
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 180, 113072
Using HPLC to analyze (S)-oxiracetam and four related substances in the bulk drug of (S)-oxiracetam
- 26 December 2019
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 17 (2) , 373-391
Hydrogel-Based Controlled Drug Delivery for Cancer Treatment: A Review
As an emerging drug carrier, hydrogels have been widely used for tumor drug delivery. A hydrogel drug carrier can cause less severe side effects than systemic chemotherapy and can achieve sustained delivery of a drug at tumor sites. In addition, hydrogels have excellent biocompatibility and biodegradability and lower toxicity than nanoparticle carriers. Smart hydrogels can respond to stimuli in the environment (e.g., heat, pH, light and ultrasound), enabling in situ gelation and controlled drug release, which greatly enhance the convenience and efficiency of drug delivery. Here, we summarize the different sizes of hydrogels used for cancer treatment and their related delivery routes, discuss the design strategies for stimuli-responsive hydrogels, and review the research concerning smart hydrogels reported in the past few years.
- 26 December 2019
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 17 (2) , 373-391
Hydrogel-Based Controlled Drug Delivery for Cancer Treatment: A Review
As an emerging drug carrier, hydrogels have been widely used for tumor drug delivery. A hydrogel drug carrier can cause less severe side effects than systemic chemotherapy and can achieve sustained delivery of a drug at tumor sites. In addition, hydrogels have excellent biocompatibility and biodegradability and lower toxicity than nanoparticle carriers. Smart hydrogels can respond to stimuli in the environment (e.g., heat, pH, light and ultrasound), enabling in situ gelation and controlled drug release, which greatly enhance the convenience and efficiency of drug delivery. Here, we summarize the different sizes of hydrogels used for cancer treatment and their related delivery routes, discuss the design strategies for stimuli-responsive hydrogels, and review the research concerning smart hydrogels reported in the past few years.
- Top Cited Papers
- 13 August 2018
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 12 (8) , 8308-8322
Tumor Oxygenation and Hypoxia Inducible Factor-1 Functional Inhibition via a Reactive Oxygen Species Responsive Nanoplatform for Enhancing Radiation Therapy and Abscopal Effects
Hypoxia, and hypoxia inducible factor-1 (HIF-1), can induce tumor resistance to radiation therapy. To overcome hypoxia-induced radiation resistance, recent studies have described nanosystems to improve tumor oxygenation for immobilizing DNA damage and simultaneously initiate oxygen-dependent HIF-1α degradation. However, HIF-1α degradation is incomplete during tumor oxygenation treatment alone. Therefore, tumor oxygenation combined with residual HIF-1 functional inhibition is crucial to optimizing therapeutic outcomes of radiotherapy. Here, a reactive oxygen species (ROS) responsive nanoplatform is reported to successfully add up tumor oxygenation and HIF-1 functional inhibition. This ROS responsive nanoplatform, based on manganese dioxide (MnO2) nanoparticles, delivers the HIF-1 inhibitor acriflavine and other hydrophilic cationic drugs to tumor tissues. After reacting with overexpressed hydrogen peroxide (H2O2) within tumor tissues, Mn2+ and oxygen molecules are released for magnetic resonance imaging and tumor oxygenation, respectively. Cooperating with the HIF-1 functional inhibition, the expression of tumor invasion-related signaling molecules (VEGF, MMP-9) is obviously decreased to reduce the risk of metastasis. Furthermore, the nanoplatform could relieve T-cell exhaustion via downregulation of PD-L1, whose effects are similar to the checkpoint inhibitor PD-L1 antibody, and subsequently activates tumor-specific immune responses against abscopal tumors. These therapeutic benefits including increased X-ray-induced damage, downregulated resistance, and T-cell exhaustion related proteins expression achieved synergistically the optimal inhibition of tumor growth. Overall, this designed ROS responsive nanoplatform is of great potential in the sensitization of radiation for combating primary and metastatic tumors.
- 13 August 2018
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 12 (8) , 8308-8322
Top Cited PapersTumor Oxygenation and Hypoxia Inducible Factor-1 Functional Inhibition via a Reactive Oxygen Species Responsive Nanoplatform for Enhancing Radiation Therapy and Abscopal Effects
Hypoxia, and hypoxia inducible factor-1 (HIF-1), can induce tumor resistance to radiation therapy. To overcome hypoxia-induced radiation resistance, recent studies have described nanosystems to improve tumor oxygenation for immobilizing DNA damage and simultaneously initiate oxygen-dependent HIF-1α degradation. However, HIF-1α degradation is incomplete during tumor oxygenation treatment alone. Therefore, tumor oxygenation combined with residual HIF-1 functional inhibition is crucial to optimizing therapeutic outcomes of radiotherapy. Here, a reactive oxygen species (ROS) responsive nanoplatform is reported to successfully add up tumor oxygenation and HIF-1 functional inhibition. This ROS responsive nanoplatform, based on manganese dioxide (MnO2) nanoparticles, delivers the HIF-1 inhibitor acriflavine and other hydrophilic cationic drugs to tumor tissues. After reacting with overexpressed hydrogen peroxide (H2O2) within tumor tissues, Mn2+ and oxygen molecules are released for magnetic resonance imaging and tumor oxygenation, respectively. Cooperating with the HIF-1 functional inhibition, the expression of tumor invasion-related signaling molecules (VEGF, MMP-9) is obviously decreased to reduce the risk of metastasis. Furthermore, the nanoplatform could relieve T-cell exhaustion via downregulation of PD-L1, whose effects are similar to the checkpoint inhibitor PD-L1 antibody, and subsequently activates tumor-specific immune responses against abscopal tumors. These therapeutic benefits including increased X-ray-induced damage, downregulated resistance, and T-cell exhaustion related proteins expression achieved synergistically the optimal inhibition of tumor growth. Overall, this designed ROS responsive nanoplatform is of great potential in the sensitization of radiation for combating primary and metastatic tumors.
- 1 November 2016
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 133, 211-217
Carbon and Metal Quantum Dots toxicity on the microalgae Chlorella pyrenoidosa
- 1 November 2016
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 133, 211-217
Carbon and Metal Quantum Dots toxicity on the microalgae Chlorella pyrenoidosa
- 2 February 2016
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 6 (34) , 28187-28193
Fluorescent yeast containing intracellularly biosynthesized CdSe QDs as a sensitive probe for simple determination of copper(ii) in water and plasma
CdSe QDs were attentively biosynthesized in yeast, and these yeasts can be used as a fluorescent probe for tracing Cu2+in water and plasma.
- 2 February 2016
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 6 (34) , 28187-28193
Fluorescent yeast containing intracellularly biosynthesized CdSe QDs as a sensitive probe for simple determination of copper(ii) in water and plasma
CdSe QDs were attentively biosynthesized in yeast, and these yeasts can be used as a fluorescent probe for tracing Cu2+in water and plasma.
- 7 September 2015
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 5 (96) , 79184-79191
Crucial factors in biosynthesis of fluorescent CdSe quantum dots in Saccharomyces cerevisiae
Cadmium selenium (CdSe) quantum dots (QDs) were synthesized using Saccharomyces cerevisiae (ATCC9763) as a biomatrix cultured with 5 mmol L−1 Na2SeO3 and 1 mmol L−1 CdCl2. Five decisive factors in the biomanufacture of CdSe QDs in S. cerevisiae were investigated and optimized, including the time point of adding Na2SeO3, the optimal concentrations of selenite and cadmium, and the incubating duration of selenite and cadmium with yeast cells respectively. By exploiting two dependent metabolic pathways in an appropriate procedure, CdSe QDs were obtained simply with controllable particle size and tunable fluorescence emission. With the help of an effective extracting method, the maximum emission peaks of different isolated QDs had been further detected, with adjustable wavelengths ranging from 506 nm (green) to 562 nm (yellow). The following in vitro 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay revealed that the biocomposed CdSe QDs had much lower cytotoxicity compared with hydrothermally synthesized thioglycolic acid (TGA)-capped CdSe and TGA capped-CdTe. By the advantages of the operational protocol, these findings exhibited the potential of an uncomplicated biosynthetic method which is capable of producing easily detectable, environment-friendly and low toxic inorganic nanoparticles with easy access of raw materials.
- 7 September 2015
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 5 (96) , 79184-79191
Crucial factors in biosynthesis of fluorescent CdSe quantum dots in Saccharomyces cerevisiae
Cadmium selenium (CdSe) quantum dots (QDs) were synthesized using Saccharomyces cerevisiae (ATCC9763) as a biomatrix cultured with 5 mmol L−1 Na2SeO3 and 1 mmol L−1 CdCl2. Five decisive factors in the biomanufacture of CdSe QDs in S. cerevisiae were investigated and optimized, including the time point of adding Na2SeO3, the optimal concentrations of selenite and cadmium, and the incubating duration of selenite and cadmium with yeast cells respectively. By exploiting two dependent metabolic pathways in an appropriate procedure, CdSe QDs were obtained simply with controllable particle size and tunable fluorescence emission. With the help of an effective extracting method, the maximum emission peaks of different isolated QDs had been further detected, with adjustable wavelengths ranging from 506 nm (green) to 562 nm (yellow). The following in vitro 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay revealed that the biocomposed CdSe QDs had much lower cytotoxicity compared with hydrothermally synthesized thioglycolic acid (TGA)-capped CdSe and TGA capped-CdTe. By the advantages of the operational protocol, these findings exhibited the potential of an uncomplicated biosynthetic method which is capable of producing easily detectable, environment-friendly and low toxic inorganic nanoparticles with easy access of raw materials.